Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Validation Studies
100%
Non-associated
100%
C-reactive Protein
100%
Chlamydia Trachomatis Infection
100%
Clinical Validation
100%
Tubal Factor Infertility
100%
Laparoscopy
37%
Low-grade Inflammation
37%
Amsterdam
37%
C-reactive Protein Level
37%
Endometriosis
25%
University Medical Centre
25%
Fertility Work-up
25%
Invasive Diagnostic Procedures
25%
Antibody Test
12%
Female Patients
12%
Netherlands
12%
High Risk
12%
Odds Ratio
12%
Clinical Policy
12%
Maastricht University
12%
Chlamydia Trachomatis
12%
Patient Demographics
12%
Competing Interests
12%
Diagnostic Test
12%
Spin-off Companies
12%
Clinical Validity
12%
Positivity Rate
12%
Inclusion Criteria
12%
Small Sample Size
12%
Medical Data
12%
Inflammatory Markers
12%
High-sensitivity C-reactive Protein (hs-CRP)
12%
Tertiary Care Hospital
12%
Clinical High Risk
12%
Serum Samples
12%
Peri
12%
Host Factors
12%
Clinical Utility
12%
Retrospective Cohort
12%
Immunogenetics
12%
IgG Antibody
12%
Chart Review
12%
Serum C-reactive Protein
12%
CRP Levels
12%
Hysterosalpingography
12%
Pelvic Surgery
12%
Menstrual Cycle
12%
Infection Prevention
12%
Distal Occlusion
12%
Center Location
12%
Setting Method
12%
Medical Microbiology
12%
Peritubal Adhesions
12%
Elevated CRP
12%
Tubular Function
12%
Fertility Clinics
12%
One-tube
12%
Full-time Employee
12%
Noninvasive Risk Assessment Tests
12%
INIS
validation
100%
cats
100%
c-reactive protein
100%
women
60%
levels
40%
patients
40%
inflammation
40%
risks
30%
fertility
30%
size
20%
universities
20%
medical centers
20%
elisa
20%
testing
10%
data
10%
antibodies
10%
sensitivity
10%
surgery
10%
females
10%
diagnosis
10%
tubes
10%
policy
10%
netherlands
10%
reviews
10%
design
10%
populations
10%
evaluation
10%
risk assessment
10%
inclusions
10%
utilities
10%
employees
10%
host
10%
grants
10%
spin-off
10%
adhesion
10%
charts
10%
menstrual cycle
10%
Medicine and Dentistry
C Reactive Protein
100%
Chlamydia Infection
100%
Laparoscopic Surgery
30%
Enzyme Linked Immunosorbent Assay
20%
Body Mass Index
20%
Endometriosis
20%
Invasive Diagnostics
20%
Retrospective Study
10%
Patient Population
10%
Chlamydia Trachomatis
10%
Medical Microbiology
10%
False Positive Result
10%
Tertiary Care
10%
Immunoglobulin G Antibody
10%
Infection Prevention
10%
Host Factor
10%
Pelvis Surgery
10%
Menstrual Cycle
10%
Immunogenetics
10%
Hysterosalpingography
10%
Odds Ratio
10%
Diagnostic Testing
10%
Pharmacology, Toxicology and Pharmaceutical Science
C Reactive Protein
100%
Chlamydiasis
100%
Inflammation
30%
Enzyme-Linked Immunosorbent Assay
20%
Endometriosis
20%
Infection
10%
Retrospective Study
10%
Host Factor
10%
Chlamydia Trachomatis
10%
Immunoglobulin G Antibody
10%
Immunology and Microbiology
C-Reactive Protein
100%
Chlamydia Trachomatis
100%
ELISA
20%
Medical Microbiology
10%
Pelvis
10%
Host Factor
10%
Sample Size
10%
Immunoglobulin G Antibody
10%
Menstrual Cycle
10%
Immunogenetics
10%